Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma

Immune checkpoint inhibitors (ICI) have drastically changed the landscape of metastatic melanoma management, thus significantly improving survival. Clinically, assessing treatment response may be challenging in a portion of cases due to a massive influx of immune cells into the tumor microenvironmen...

Full description

Bibliographic Details
Main Authors: Diogo Garcia, Juliana Rodrigues Beal, Daniel Mamere Alvarez, Ricardo Silvestre e Silva Macarenco, Gustavo Schvartsman
Format: Article
Language:English
Published: Karger Publishers 2021-06-01
Series:Case Reports in Oncology
Subjects:
melanoma
pd-1 receptor
immunotherapy
ctla-4 receptor
recist
Online Access:https://www.karger.com/Article/FullText/516036

Similar Items

Similar Items